Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients
gracevideo
Author
GRACE Videos and Articles

Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February 2014.

[powerpress]

Tags
acquired resistance
CO-1686
Current Clinical Trials
Dr. Heather Wakelee
EGFR
Lung Cancer
Stanford University Medical Center
targeted therapy

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

What is the AVO treatment for Chronic Lymphocytic Leukemia (CLL)? Acalabrutinib, Venetoclax, Obinutuzumab for High-Risk Patients
Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Targeted Therapies 2025
Targeted Therapies in Lung Cancer Patient Forum
Video
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
2025 Foro de Pacientes de Terapias Dirigidas de Cancer de Pulmon
Article
Da click aquí para más información y para registrarte ahora

Forum Discussions

Recent Comments

JOIN THE CONVERSATION
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
colon cancer and HIV
By Hopish hope on
Targeted Therapies in Lung Cancer March 2025
Thank you for sharing
By LeviDrake on
Multiple EGFR mutation lung cancer
Hi bluesun,I don't know of…
By JanineT GRACE … on